Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CEPI
Research
First Bundibugyo Ebola vaccine to enter phase 1 trials
The ChAdOx1 BDBV vaccine uses the same platform as the AstraZeneca COVID-19 vaccine.
Marissa Russo
Jul 14, 2026 12:18pm
CEPI to fund Moderna's pandemic flu trial after HHS walked away
Dec 18, 2025 9:40am
Barinthus' gets $35M booster from CEPI to develop MERS shot
Dec 21, 2023 10:10am
CEPI's founding CEO to lead Wellcome—Chutes & Ladders
Oct 13, 2023 9:30am
IQVIA teams with CEPI to address future global disease outbreaks
Oct 12, 2023 7:20am
BioNTech pockets $90M from CEPI to partner on mpox vaccine
Sep 18, 2023 10:30am
